123 related articles for article (PubMed ID: 27766925)
1. Is gentamicin necessary in the antimicrobial treatment for group B streptococcal infections in the elderly? An in vitro study with human blood products.
Ruppen C; Decosterd L; Sendi P
Infect Dis (Lond); 2017 Mar; 49(3):185-192. PubMed ID: 27766925
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of gentamicin as an adjunct to penicillin against biofilm group B Streptococcus.
Ruppen C; Hemphill A; Sendi P
J Antimicrob Chemother; 2017 Feb; 72(2):444-447. PubMed ID: 27999071
[TBL] [Abstract][Full Text] [Related]
3. [Optimum choice of antibiotic treatment in neonatal infections due to group B streptococci].
Bingen E; Lambert-Zechovsky N; Guihaire E; Mancy C; Aujard Y; Mathieu H
Pathol Biol (Paris); 1986 May; 34(5):530-3. PubMed ID: 3534738
[TBL] [Abstract][Full Text] [Related]
4. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.
Swingle HM; Bucciarelli RL; Ayoub EM
J Infect Dis; 1985 Sep; 152(3):515-20. PubMed ID: 3897398
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of bactericidal activity against group B streptococci with reduced penicillin susceptibility by uptake of gentamicin into cells resulting from combination with β-lactam antibiotics.
Ebara Y; Morozumi M; Sato M; Moritoki N; Toyofuku M; Takata M; Murata M; Ubukata K; Iwata S
J Infect Chemother; 2017 May; 23(5):312-318. PubMed ID: 28341517
[TBL] [Abstract][Full Text] [Related]
6. Chromosomally and Extrachromosomally Mediated High-Level Gentamicin Resistance in Streptococcus agalactiae.
Sendi P; Furitsch M; Mauerer S; Florindo C; Kahl BC; Shabayek S; Berner R; Spellerberg B
Antimicrob Agents Chemother; 2016 Jan; 60(3):1702-7. PubMed ID: 26729498
[TBL] [Abstract][Full Text] [Related]
7. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.
Baker CN; Thornsberry C; Facklam RR
Antimicrob Agents Chemother; 1981 May; 19(5):716-25. PubMed ID: 7027921
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic-killing kinetics of group B streptococci.
Schauf V; Deveikis A; Riff L; Serota A
J Pediatr; 1976 Aug; 89(2):194-8. PubMed ID: 781200
[TBL] [Abstract][Full Text] [Related]
9. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
Cercenado E; Díaz MD; Sánchez-Carrillo C; Vicente T; Bernaldo de Quirós JC
Antimicrob Agents Chemother; 1995 Dec; 39(12):2816-8. PubMed ID: 8593029
[TBL] [Abstract][Full Text] [Related]
10. Serious infection in an adult due to penicillin-tolerant group B streptococcus.
Steinbrecher UP
Arch Intern Med; 1981 Nov; 141(12):1714-5. PubMed ID: 7030251
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa.
Bolukaoto JY; Monyama CM; Chukwu MO; Lekala SM; Nchabeleng M; Maloba MR; Mavenyengwa RT; Lebelo SL; Monokoane ST; Tshepuwane C; Moyo SR
BMC Res Notes; 2015 Aug; 8():364. PubMed ID: 26289147
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
Villar H; Jugo M; Farinati A
Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):385-9. PubMed ID: 7981289
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of GBS.
Kim KS
Antibiot Chemother (1971); 1985; 35():83-9. PubMed ID: 3901912
[No Abstract] [Full Text] [Related]
14. Bactericidal studies of penicillin-gentamicin combinations against group B streptococci.
Overturf GD; Horowitz M; Wilkins J; Leedom J; Steinberg E
J Antibiot (Tokyo); 1977 Jun; 30(6):513-8. PubMed ID: 328471
[TBL] [Abstract][Full Text] [Related]
15. Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy.
Levine JF; Hanna BA; Pollock AA; Simberkoff MS; Rahal JJ
Am J Med Sci; 1983; 286(1):31-6. PubMed ID: 6553451
[TBL] [Abstract][Full Text] [Related]
16. Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria.
Kim KS
J Infect Dis; 1987 Jun; 155(6):1233-41. PubMed ID: 3553349
[TBL] [Abstract][Full Text] [Related]
17. [Emergence of high-level resistance to gentamicin and streptomycin in Streptococcus agalactiae in Buenos Aires, Argentina].
Villar HE; Jugo MB
Rev Esp Quimioter; 2013 Jun; 26(2):112-5. PubMed ID: 23817648
[TBL] [Abstract][Full Text] [Related]
18. Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland.
Cooper K; Abbott F; Gould IM
Br J Biomed Sci; 2016; 73(1):25-7. PubMed ID: 27182673
[No Abstract] [Full Text] [Related]
19. Susceptibility to six antibiotics of group B streptococci isolated from cerebrospinal fluid.
Mulder C; Bol P; Nabbe A; Zanen B
Scand J Infect Dis; 1985; 17(2):191-3. PubMed ID: 3895400
[TBL] [Abstract][Full Text] [Related]
20. Is Penicillin Plus Gentamicin Synergistic against Clinical Group B
Ruppen C; Lupo A; Decosterd L; Sendi P
Front Microbiol; 2016; 7():1680. PubMed ID: 27818657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
